Microsoft ruminating on suing OpenAI over Altman's recent deal with Amazon ...

AI-powered dictation startup Wispr Flow has launched its Android app today. The company released its app for Mac and Windows first, then launched on iOS in June 2025. On iOS, users could use Wispr ...

Website owners are reporting a sharp spike in the number of bots visiting their platforms in recent months. While the bots’ function is unclear, experts say they could represent an attempt to scrape ...

Sign of the times: An AI agent autonomously wrote and published a personalized attack article against an open-source software maintainer after he rejected its code contribution. It might be the first ...

OpenClaw, a powerful new agentic assistant, has a thing for guacamole. This is one of several things I discovered while using the viral artificial intelligence bot as my personal assistant this past ...

A new website called Moltbook has become the talk of Silicon Valley and a Rorschach test for belief in the state of artificial intelligence. By Cade Metz Reporting from San Francisco Last Wednesday, ...

Recent discussions of conversational artificial intelligence have raised serious questions about mental health. For some people who use these systems regularly, the interaction can feel meaningful and ...

When a friend messaged me two days ago about Clawdbot—a new open-source AI agent that has since been renamed OpenClaw—I expected yet another disappointing “assistant.” But it was already a viral ...

Dan Peguine, a tech entrepreneur and marketing consultant based in Lisbon, lets a precocious, lobster-themed AI assistant called Moltbot run much of his life. Peguine, a self-professed early adopter ...

Interest in Clawdbot, an open-source AI personal assistant, has been building from a simmer to a roar. Over the weekend, online chatter about the tool reached viral status — at least, as viral as an ...

Microsoft is a terrific growth stock with an excellent dividend program. Johnson & Johnson and Coca-Cola are both outstanding dividend payers. However, neither has the high-growth outlook that ...